drugset / Trial / NCT07853248
Tegoprazan-Aspirin Drug Interaction in Healthy Adult Male Volunteers
NaSingle-groupOpen-labelTreatment
Summary
This Clinical Trial Aims to Evaluate the PK/PD Drug-Drug Interaction and Safety/Tolerability of Tegoprazan and Aspirin in Healthy Adult Male Volunteers.
Timeline
- Start
- 2026-10-14
- Primary completion
- 2027-01-31
- Completion
- 2027-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 100 mg | — |
| Subject | Tegoprazan | Other / unclassified | 50 mg | — |
Indications
No indication recorded.